(Government of Manitoba/Supplied)
Article continues below advertisement ↴
The province says that they have the ability to distribute the COVID-19 vaccine quickly, yet over 5,000 doses remain unclaimed.
A limited set of criteria has been released of who will receive the Pfizer COVID-19 vaccine, focussing on those on the front line of COVID-19 healthcare. No other anticipated priority groups for the Pfizer vaccine have been released as the province is only releasing the list of those eligible as vaccines become available. During a Wednesday press conference, Premier Brian Pallister says he expects age will be a factor in the groups.
In total, 5,165 people have been immunized using the Pfizer vaccine. Manitoba has received 22,230 doses of this company s vaccine.
Covid 19 coronavirus: Here s what people with allergies should know about vaccines
21 Dec, 2020 07:15 PM
9 minutes to read
New York Times
By: Katherine J. Wu
Four people so far have had allergic reactions after getting the Pfizer-BioNTech vaccine. Experts say that shouldn t deter most people from getting a jab. Allergic reactions reported in two health workers who received a dose of Pfizer s vaccine in Alaska this week have reignited concerns that people with a history of extreme immune flare-ups might not be good candidates for the newly cleared shots.
The two incidents follow another pair of cases in Britain. Three of the four were severe enough to qualify as anaphylaxis, a severe and potentially life-threatening reaction. But all four people appear to have recovered.
Hereâs what people with allergies should know about COVID vaccines
By Katherine J. Wu New York Times,Updated December 18, 2020, 3:33 p.m.
Email to a Friend
Mary Ezzat inoculates fellow health care worker Angela Serrano with the Pfizer-BioNTech COVID-19 vaccine in a temporary structure at UCI Medical Center in Orange, Calif., Dec. 16, 2020.Jenna Schoenefeld/NYT
Allergic reactions reported in two health workers who received a dose of Pfizerâs vaccine in Alaska this week have reignited concerns that people with a history of extreme immune flare-ups might not be good candidates for the newly cleared shots.
The two incidents follow another pair of cases in Britain. Three of the four were severe enough to qualify as anaphylaxis, a severe and potentially life-threatening reaction. But all four people appear to have recovered.
Here s what people with allergies should know about COVID vaccines baltimoresun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baltimoresun.com Daily Mail and Mail on Sunday newspapers.
The two incidents follow another pair of cases in Britain. Three of the four were severe enough to qualify as anaphylaxis, a severe and potentially life-threatening reaction. But all four people appear to have recovered.
Health officials on both sides of the pond are vigilantly monitoring vaccinated people to see if more cases emerge. Last week, British drug regulators recommended against the use of Pfizer’s vaccine in people who have previously had anaphylactic reactions to food, medicines or vaccines.
And on Thursday, Dr. Doran Fink, deputy director of the Food and Drug Administration’s clinical division of vaccines and related products applications, addressed the issue during a meeting about the vaccine made by Moderna that contains similar ingredients and is expected to soon receive emergency use authorization, or E.U.A., from the agency.